• CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Prescott, AZ

    Northern Arizona VAHCS 500 N Hwy 89, Prescott, AZ, United States

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • Rethinking HCC – Bay Pines, FL

    Bay Pines VA Healthcare System Building 20 Auditorium, 10,000 Bay Pines Blvd, Bay Pines, FL, United States

    This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).

  • Hemophilia A – Brooklyn, NY

    The Brooklyn Hospital Center 121 DeKalb Avenue, Brooklyn, NY, United States

    This case-based live activity will cover the treatment and management of patients with hemophilia A

  • CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Nashville, TN

    Meharry Medical College 1005 Dr. D.B.Todd Jr. Blvd, Nashville, TN, United States

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Lebanon, PA

    Wellspan Good Samaritan Hospital 252 S. 4th St 4th and Walnut St, Lebanon, PA, United States

    This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

  • Atopic Derm – Mayfield Heights, OH

    This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.

  • Hemophilia A – Savannah, GA

    This case-based live activity will cover the treatment and management of patients with hemophilia A